Breaking News Instant updates and real-time market news.

DKS

Dick's Sporting

$30.66

0.79 (2.64%)

07:31
02/07/18
02/07
07:31
02/07/18
07:31

Dick's Sporting risk/reward 'highly attractive,' says JPMorgan

JPMorgan analyst Christopher Horvers sees a "highly attractive" risk/reward in shares of Dick's Sporting Goods following the recent selloff. The analyst believes the Eagles Super Bowl win and new Little League bat regulations could provide a near-term lift in comp sales. He keeps an Overweight rating on Dick's with a $43 price target.

DKS Dick's Sporting
$30.66

0.79 (2.64%)

01/25/18
TLSY
01/25/18
UPGRADE
Target $42
TLSY
Outperform
Dick's Sporting upgraded to Outperform at Telsey Advisory
Telsey Advisory analyst Joseph Feldman upgraded Dick's Sporting Goods to Outperform with a $42 price target, up from $25. Feldman expects industry pressures to stabilize as we enter Q2, benefiting results in 2H 2018, and expects tax reform to flow through to earnings.
01/25/18
01/25/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Grainger (GWW) upgraded to Outperform from Neutral at Baird with analyst David Manthey saying its strategic initiatives are gaining traction faster than expected. 2. Carter's (CRI) upgraded to Outperform from Market Perform at Wells Fargo with analyst Ike Boruchow saying his store work and industry reads give him confidence that Carter's comps should come in above plan. 3. CenturyLink (CTL) upgraded to Outperform from Sector Perform at RBC Capital with analyst Jonathan Atkin saying there is potential upside to the company's synergy targets, adding that he believes the new management can restructure operations to generate EBITDA growth. 4. Lowe's (LOW), Dick's Sporting (DKS), and Michaels (MIK) were upgraded to Outperform from Market Perform at Telsey Advisory. 5. Varian Medical (VAR) upgraded to Outperform from Market Perform at Barrington with analyst Michael Petusky saying he views the company's first quarter results as "strong" and believes the outlook for 2018 is likely conservative. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
02/05/18
LEHM
02/05/18
DOWNGRADE
Target $25
LEHM
Underweight
Dick's Sporting downgraded to Underweight from Equal Weight at Barclays
Barclays analyst Matthew McClintock downgraded Dick's Sporting Goods (DKS) to Underweight and cut his price target for the shares to $25 from $33. Sentiment on the shares have improved over the past month under the narrative that Dick's could become the next Best Buy (BBY), McClintock tells investors in a research note. The analyst, however, sees few, if any, similarities between the two companies. He questions how the Dick's business model of a "physical sporting goods box with a sparse labor model and no treasure hunt aspects will remain relevant as changing consumer preference." The company is facing accelerating competitive pressures in apparel and has substantial exposure to weak hunting trends, McClintock adds.
02/05/18
02/05/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Wells Fargo (WFC) downgraded to Market Perform from Outperform at Keefe Bruyette, to Neutral from Buy at Citi, to Underperform from Outperform at RBC Capital, to Underweight from Neutral at JPMorgan, and two notches to Underweight from Overweight at Morgan Stanley. 2. Dick's Sporting (DKS) downgraded to Underweight from Equal Weight at Barclays with analyst Matthew McClintock saying sentiment on the shares have improved over the past month under the narrative that Dick's could become the next Best Buy (BBY). 3. Amgen (AMGN) downgraded to Neutral from Overweight at Atlantic Equities with analyst Steve Chesney citing relative valuation and more balanced risk/reward on Repatha's commercial trajectory and the of legacy biologics given biosimilar, branded and IP risks. 4. Marathon Petroleum (MPC) and MPLX (MPLX) were downgraded to Hold from Buy at Jefferies. 5. VMware (VMW) downgraded to Neutral from Buy at Citi with analyst Walter Pritchard saying he sees "no easy deal" for Dell and expects the overhang to cap VMware shares around the $138 level. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

VYGR

Voyager Therapeutics

$23.66

4.3 (22.21%)

, ABBV

AbbVie

$117.98

-0.62 (-0.52%)

08:05
02/21/18
02/21
08:05
02/21/18
08:05
Recommendations
Voyager Therapeutics, AbbVie analyst commentary  »

Voyager Therapeutics…

VYGR

Voyager Therapeutics

$23.66

4.3 (22.21%)

ABBV

AbbVie

$117.98

-0.62 (-0.52%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Mar

CATS

Catasys

$4.37

0.05 (1.16%)

08:05
02/21/18
02/21
08:05
02/21/18
08:05
Hot Stocks
Catasys announces launch of enrollment with national health insurer »

Catasys announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

08:05
02/21/18
02/21
08:05
02/21/18
08:05
General news
Fedspeak resumes after a hiatus: »

Fedspeak resumes after a…

CQH

Cheniere Energy Partners LP

$28.11

0.11 (0.39%)

08:03
02/21/18
02/21
08:03
02/21/18
08:03
Hot Stocks
Breaking Hot Stocks news story on Cheniere Energy Partners LP »

Cheniere Energy Partners…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

MTCH

Match Group

$42.10

0.54 (1.30%)

08:03
02/21/18
02/21
08:03
02/21/18
08:03
Technical Analysis
Technical Take: Match Group slides in early trading, analyst action »

The stock was last down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MO

Altria Group

$64.19

-1.27 (-1.94%)

08:03
02/21/18
02/21
08:03
02/21/18
08:03
Earnings
Altria Group reaffirms FY18 adjusted EPS view $3.90-$4.03, consensus $4.01 »

Altria reaffirms its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

CQH

Cheniere Energy Partners LP

$28.11

0.11 (0.39%)

08:03
02/21/18
02/21
08:03
02/21/18
08:03
Earnings
Breaking Earnings news story on Cheniere Energy Partners LP »

Cheniere Energy Partners…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

ABBV

AbbVie

$117.98

-0.62 (-0.52%)

, NBIX

Neurocrine

$84.58

-0.67 (-0.79%)

08:03
02/21/18
02/21
08:03
02/21/18
08:03
Hot Stocks
AbbVie: Phase 3 ELARIS UF-I study of elagolix met primary endpoint »

AbbVie (ABBV) in…

ABBV

AbbVie

$117.98

-0.62 (-0.52%)

NBIX

Neurocrine

$84.58

-0.67 (-0.79%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Mar

VG

Vonage

$11.47

0.28 (2.50%)

08:03
02/21/18
02/21
08:03
02/21/18
08:03
Earnings
Vonage sees 2018 revenue $1.03B-$1.05B, consensus $1.03B »

Sees 2018 Capex of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 14

    Mar

CQP

Cheniere Energy Partners

$29.65

0.48 (1.65%)

08:02
02/21/18
02/21
08:02
02/21/18
08:02
Earnings
Breaking Earnings news story on Cheniere Energy Partners »

Cheniere Energy Partners…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

CQP

Cheniere Energy Partners

$29.65

0.48 (1.65%)

08:02
02/21/18
02/21
08:02
02/21/18
08:02
Earnings
Breaking Earnings news story on Cheniere Energy Partners »

Cheniere Energy Partners…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

VG

Vonage

$11.47

0.28 (2.50%)

08:02
02/21/18
02/21
08:02
02/21/18
08:02
Earnings
Vonage reports Q4 adjusted EPS 9c, consensus 9c »

Reports Q4 revenue $254M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 14

    Mar

PANW

Palo Alto Networks

$162.92

0.84 (0.52%)

08:01
02/21/18
02/21
08:01
02/21/18
08:01
Upgrade
Palo Alto Networks rating change  »

Palo Alto Networks…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

  • 26

    Feb

  • 04

    Mar

  • 14

    Mar

ANY

Sphere 3D

$2.34

0.0101 (0.43%)

08:00
02/21/18
02/21
08:00
02/21/18
08:00
Hot Stocks
Breaking Hot Stocks news story on Sphere 3D »

Sphere 3D trading halted,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

08:00
02/21/18
02/21
08:00
02/21/18
08:00
General news
U.S. chain store sales fell 0.6% to 115.8 in the week ended February 17 »

U.S. chain store sales…

DPZ

Domino's Pizza

$221.49

0.75 (0.34%)

07:59
02/21/18
02/21
07:59
02/21/18
07:59
Recommendations
Domino's Pizza analyst commentary  »

Domino's Pizza price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 30

    May

IPHI

Inphi

$25.20

0.76 (3.11%)

07:59
02/21/18
02/21
07:59
02/21/18
07:59
Recommendations
Inphi analyst commentary  »

Inphi weakness a buying…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

NTDOY

Nintendo

$54.25

0.1 (0.18%)

07:59
02/21/18
02/21
07:59
02/21/18
07:59
Periodicals
Nintendo accused of illegally denying refunds on pre-orders, TechCrunch says »

Nintendo has been accused…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SSTI

ShotSpotter

$20.00

0.03 (0.15%)

07:58
02/21/18
02/21
07:58
02/21/18
07:58
Earnings
ShotSpotter raises FY18 revenue view to $31M-$33M from $30M-$32M »

ShotSpotter expects FY18…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Mar

SAFM

Sanderson Farms

$131.44

-1.97 (-1.48%)

07:57
02/21/18
02/21
07:57
02/21/18
07:57
Initiation
Sanderson Farms initiated  »

Sanderson Farms initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 29

    Mar

UMICY

Umicore

$14.20

-0.48 (-3.27%)

07:57
02/21/18
02/21
07:57
02/21/18
07:57
Conference/Events
Umicore management to meet with JPMorgan »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 22

    Feb

  • 23

    Feb

SPN

Superior Energy

$9.37

0.46 (5.16%)

07:56
02/21/18
02/21
07:56
02/21/18
07:56
Upgrade
Superior Energy rating change  »

Superior Energy upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

SSTI

ShotSpotter

$20.00

0.03 (0.15%)

07:55
02/21/18
02/21
07:55
02/21/18
07:55
Earnings
ShotSpotter reports Q4 EPS (26c), two estimates (9c) »

Reports Q4 revenue $6.5M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Mar

DIN

DineEquity

$63.44

8.77 (16.04%)

07:55
02/21/18
02/21
07:55
02/21/18
07:55
Conference/Events
DineEquity to host investor day »

Investor Day to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 26

    Feb

IPXL

Impax

$19.70

0.1 (0.51%)

07:54
02/21/18
02/21
07:54
02/21/18
07:54
Hot Stocks
Amneal launches memantine hydrochloride extended-release capsules »

Amneal Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Mar

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.